$62.00
Neil Wagner (Editor)
Series: Women’s Issues
BISAC: SOC028000
Women make up over half the U.S. population, but historically have been underrepresented in clinical research supported by the National Institutes of Health (NIH) and others. As a result, differences in the manifestation of certain diseases and reactions to treatment in women compared with men were not identified. For example, there have been instances of women having adverse effects that differed from those of men related to medications and other treatments. NIH’s Inclusion Policy established requirements governing women’s inclusion in its clinical research. This book examines women’s enrollment and NIH’s efforts to monitor this enrollment in NIH-funded clinical research; and NIH’s efforts to ensure that NIH-funded clinical trials are designed and conducted to analyze potential sex differences, when applicable. (Imprint: Novinka)
Table of Contents
Preface
Chapter 1. National Institutes of Health: Better Oversight Needed to Help Ensure Continued Progress Including Women in Health Research
United States Government Accountability Office
Chapter 2. Moving into the Future with New Dimensions and Strategies: A Vision for 2020 for Women’s Health Research. Strategic Plan
Office of Research on Women’s Health
Index
We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!
